Sanofi Adr (SNY)

Nov 15, 2024

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease - Benzinga

Nov 15, 2024

Nov 12, 2024

Communiqué de presse - GlobeNewswire Inc.

Nov 12, 2024

Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024

Oct 30, 2024

Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes

Oct 30, 2024

Oct 30, 2024

Here’s Why Mastercard Incorporated (NYSE: MA) Is An Attractive Investment Right Now - Stocks Register

Oct 30, 2024

Oct 28, 2024

Sanofi (SNY) Stock Price, News, Quote & History - Yahoo Finance

Oct 28, 2024

Oct 28, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 28, 2024

Oct 28, 2024

16 New 4-Star Stocks - Morningstar

Oct 28, 2024

Oct 27, 2024

Sanofi SA (ADR: SNY) Stock Price Could Reach $63: Morningstar Research - TopNews India

Oct 27, 2024

Oct 27, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN

Oct 27, 2024

Oct 25, 2024

Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat - Investor's Business Daily

Oct 25, 2024

Oct 25, 2024

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Oct 25, 2024

Oct 24, 2024

Sanofi, HCA, Colgate-Palmolive lead Friday's earnings lineup By Investing.com - Investing.com Australia

Oct 24, 2024

Oct 24, 2024

Sanofi, HCA, Colgate-Palmolive lead Friday's earnings lineup - Investing.com

Oct 24, 2024

Oct 21, 2024

Sanofi Deal Jitters Imperil Stock’s Big Rebound - MSN

Oct 21, 2024

Oct 21, 2024

Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale - Zacks Investment Research

Oct 21, 2024

Oct 21, 2024

Proactive news headlines: Ananda, Helix Exploration, Deltic, Light Science Technologies and more - Proactive Investors UK

Oct 21, 2024

Oct 21, 2024

French govt set to take stake in Sanofi unit after PE sale - Proactive Investors Australia

Oct 21, 2024

Oct 21, 2024

Sanofi Negotiating Exclusively With CD&R For Opella 50% Stake Sale - Barchart

Oct 21, 2024

Oct 15, 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN

Oct 15, 2024

Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024

Oct 14, 2024

10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar

Oct 14, 2024

Oct 10, 2024

Sanofi ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

Oct 10, 2024

Oct 09, 2024

Ratios Reveal: Breaking Down Sanofi ADR (SNY)’s Financial Health - The Dwinnex

Oct 09, 2024

Oct 09, 2024

EXK (Endeavour Silver Corp.) may reap gains as insiders became active recently - Knox Daily

Oct 09, 2024

Oct 09, 2024

Checking in on Clear Channel Outdoor Holdings Inc. (CCO) after recent insiders movement - Knox Daily

Oct 09, 2024

Oct 09, 2024

Investing in Sanofi ADR (SNY): What You Must Know - Knox Daily

Oct 09, 2024

Oct 09, 2024

Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily

Oct 09, 2024

Oct 09, 2024

An Analysis of KE Holdings Inc ADR (BEKE)’s Potential Price Growth - Knox Daily

Oct 09, 2024

Oct 09, 2024

Europe Pruritus Therapeutics Market Size & Outlook, 2030 - Grand View Research

Oct 09, 2024

Oct 08, 2024

OTC Drug and Dietary Supplement Market Opportunities and Strategies to 2033 - GlobeNewswire Inc.

Oct 08, 2024

Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe, Providing Exposure to Individual International Companies with an Embedded Currency Hedge - PR Newswire

Oct 07, 2024

Oct 03, 2024

The SNY Stock Puzzle: Unraveling Sanofi ADR’s Fluctuating Performance - The InvestChronicle

Oct 03, 2024

Sep 27, 2024

Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent - Investor's Business Daily

Sep 27, 2024